Potential20 Jan 2024 17:51
I've been a shareholder for about 5 years and occasionally read some of the excellent and informed posters. It is a great help for those of us who struggle to understand the science and stay on top of what is going on.
My impression, rightly or wrongly, is that we have changed track slightly since I first invested, which I'm not sure why, but I'm sure the focus is the right one. I have great confidence in Prof Lindy Durrant, who I hold in the highest regard.
I am of the opinion that she does however need Corporate input and I believe this is an aspect we have been addressing.
I also see the potential for a multi bagger here, if the amazing results continue and are tested across much larger numbers. I have no idea how long that could take, but accept that it is unlikely to be overnight!.
I also don't see the future for significant gains in the hands of private shareholders. I am assuming this must come from "Pharmas" which as I understand, are never keen to take on too much risk. This tells me there is still quite a bit more to be done before they start rattling our cage.
Having said this, I understand 2024 could be an interesting year for news flow and as far as private shareholders go, could result in positive whilst limited share price gains.
I also believe that the Co. sees the need to up its game and I think I read could look to raise up to Β£60m this year to provide a step change in trial activity etc. Is that correct? How would such funds be raised? Would it be dilutive or would the overall impact of such a change in size more than compensate?
If one had to comment on risk here, how would that be articulated?
I've asked too many naive questions and will be very grateful if I get even a few answered.
Happy New Year and keep up the excellent posts. (Is it Chester, Marcus, Torquay Fan and no doubt many more who are the "experts" here, worth of taking note from. Much appreciated.